Entero Healthcare Solutions Limited (NSE:ENTERO)

Market Cap	92.14B +94.4%
Revenue (ttm)	76.44B +34.7%
Net Income	1.39B +26.1%
EPS	31.97 +26.1%
Shares Out	43.57M
PE Ratio	66.15
Forward PE	42.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	809,248
Open	2,049.00
Previous Close	2,025.40
Day's Range	1,965.60 - 2,137.60
52-Week Range	944.00 - 2,137.60
Beta	-0.32
Analysts	Strong Buy
Price Target	1,987.60 (-6.02%)
Earnings Date	Nov 5, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 4,671
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ENTERO

Financial Performance

In fiscal year 2026, NSE:ENTERO's revenue was 65.91 billion, an increase of 29.35% compared to the previous year's 50.96 billion. Earnings were 1.15 billion, an increase of 21.33%.

Analyst Summary

According to 5 analysts, the average rating for ENTERO stock is "Strong Buy." The 12-month stock price target is ₹1,988, which is a decrease of -6.02% from the latest price.

Price Target

₹1,988

(-6.02% downside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error